2017
DOI: 10.1016/j.biopha.2016.12.138
|View full text |Cite
|
Sign up to set email alerts
|

Co-delivery of docetaxel and curcumin prodrug via dual-targeted nanoparticles with synergistic antitumor activity against prostate cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
38
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 75 publications
(39 citation statements)
references
References 40 publications
0
38
0
Order By: Relevance
“…In recent years, CUR is been one of the top-selling natural edible pigments. Furthermore, CUR has broad clinical application, i.e., antioxidant activity (Esatbeyoglu et al, 2015;Llano et al, 2019;Wang et al, 2019), anti-tumor (Ohtsu et al, 2002;Kunnumakkara et al, 2007;Yan et al, 2017), anti-inflammatory (Aggarwal and Harikumar, 2009;Fadus et al, 2017;Hussain et al, 2017), and anti-hyperlipidemia (Huang et al, 2018;Panahi et al, 2018;Wang et al, 2018), and so on. In particular, bioactivities of curcumin as an effective chemopreventive agent, chemo-/radio-sensitizer for tumor cells, and chemo-/radio-protector for normal organs, are of extraordinary research interests in the literature (Farhood et al, 2018).…”
Section: Introductionmentioning
confidence: 99%
“…In recent years, CUR is been one of the top-selling natural edible pigments. Furthermore, CUR has broad clinical application, i.e., antioxidant activity (Esatbeyoglu et al, 2015;Llano et al, 2019;Wang et al, 2019), anti-tumor (Ohtsu et al, 2002;Kunnumakkara et al, 2007;Yan et al, 2017), anti-inflammatory (Aggarwal and Harikumar, 2009;Fadus et al, 2017;Hussain et al, 2017), and anti-hyperlipidemia (Huang et al, 2018;Panahi et al, 2018;Wang et al, 2018), and so on. In particular, bioactivities of curcumin as an effective chemopreventive agent, chemo-/radio-sensitizer for tumor cells, and chemo-/radio-protector for normal organs, are of extraordinary research interests in the literature (Farhood et al, 2018).…”
Section: Introductionmentioning
confidence: 99%
“…In addition, non-CNT nanoparticles have been functionalized with DTX and could mediate PCa growth inhibition in vitro and in vivo [34–39]. For instance, DTX encapsulated in PLGA-PEG nanoparticles evoked an improved inhibition of cancer cell and tumor tissue growth compared to free DTX [38]. …”
Section: Discussionmentioning
confidence: 99%
“…To further increase the targeting of NDDS to tumor tissues, several multifunctional targeting drug delivery systems using different modifications to overcome multiple barriers simultaneously have been developed [86,87]. Nanoplatform for combinational therapy using PEG, PCEC (poly("-caprolactone)-b-poly(ethylene glycol)-b-poly("-caprolactone)) and CRGDK (cell-penetrating peptide (Cys-Arg-Gly-Asp-Lys, CRGDK)) has been developed.…”
Section: Multifunctional Targeting Drug Delivery Systemsmentioning
confidence: 99%